Abstract:Background: Acute myocardial infarction (MI) has got revolutionized therapeutic strategy by applying timely reperfusion therapy in a particular increase of primary percutaneous coronary intervention. Despite this cardiac remodeling following MI are very common with high mortality. A previous study claimed that AMPK played a pivotal role in intracellular adaptation to energy stress during myocardial ischemia. However, whether AMPKγ2 subunit played an important role in MI remains poorly defined. Hypothesis: We assessed the hypothesis that AMPKγ2 played an important role in regulating MI. Methods: AMPKγ2 level in monocytes of myocardial infarction patients was tested by ELISA. Ligation of left anterior descending branch (LAD) surgery was conducted to establish MI model. Lyz2-cre AMPKγ2 and AAV carrying F4/80 promoter for macrophage-specific overexpression AMPKγ2 mice were employed to investigate the role of AMPKγ2 in macrophages derived from MI. Results: AMPKγ2 was relatively highly expressed in the spleen and macrophage. Lyz2-cre AMPKγ2 mice developed worse cardiac dysfunction post-MI by boosting macrophage infiltration and inflammation. Overexpression of AMPKγ2 in macrophages repressed its migration and inflammation and alleviated myocardial injury. Mechanistically, CXCL16-CXCR6 axis was the contributor to macrophage migration, which was alleviated by AMPKγ2 via transcriptional regulation. Further, AMPKγ2 restrained YY1 expression, a key upstream transcription factor of CXCL16, to block the migration of macrophages. AMPKγ2 promoted YY1 degradation via smurf2 mediating ubiquitin-proteasome pathway depending on AMPKα1 subunit-mediating AMPK activity. Therefore, A769662 but not Metformin alleviated AMPKγ2 deficiency-induced migration and inflammation in macrophages. Finally, IFN-γ downregulated HOXA5 to repress AMPKγ2 transcriptional activity. Consistently, AMPKγ2 was dramatically declined in monocytes of MI patients compared to the control group. Conclusion: Macrophage AMPKγ2 deficiency played an important role in cardiac dysfunction following MI by activating the YY1-CXCL16-CXCR6 axis, which can be developed as a precision therapeutic target to ameliorate cardiac remodeling post-MI.

MEK1/2-PKM2 Pathway Modulates the Immunometabolic Reprogramming of Proinflammatory Allograft-Infiltrating Macrophages During Heart Transplant Rejection

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.

BEZ235 Prolongs Murine Cardiac Allograft Survival Through the Autophagy Pathway.

Fragile TIM-4-expressing Tissue Resident Macrophages Are Migratory and Immunoregulatory

HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs.

Role of Macrophage Subsets in Chronic Allograft Rejection and Novel Strategies to Target Them.

MTHFD2 Ablation in T Cells Protects against Heart Transplant Rejection by Perturbing IRF4/PD-1 Pathway through the Metabolic-epigenetic Nexus

Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury.

Prolongation of Cardiac Allograft Survival by Inhibition of ERK1/2 Signaling in a Mouse Model

Hypoxia inducible factor 2α promotes tolerogenic macrophage development during cardiac transplantation through transcriptional regulation of colony stimulating factor 1 receptor

Exploring the molecular mechanisms of macrophages in islet transplantation using single-cell analysis

Blockade of IL-6/IL-6R Signaling Attenuates Acute Antibody-Mediated Rejection in a Mouse Cardiac Transplantation Model

Molecular imaging of innate immune cell function in transplant rejection

Single-cell transcriptomic identified HIF1A as a target for attenuating acute rejection after heart transplantation

Adoptive Transfer of Polarized M2c Macrophages Ameliorates Acute Rejection in Rat Liver Transplantation.

The Dual Regulatory Roles of Macrophages in Acute Allogeneic Organ Graft Rejection

The CaMK Family Differentially Promotes Necroptosis and Mouse Cardiac Graft Injury and Rejection

Targeting Macrophages in Organ Transplantation: A Step Toward Personalized Medicine

METTL3 inhibition reduces N6 -methyladenosine levels and prevents allogeneic CD4+ T-cell responses

Abstract 10754: AMPKγ2 Deficiency Exacerbates Macrophage Recruitment and Inflammation Post-MI Via Promoting YY1-CXCL16-CXCR6 Axis